nifedipine has been researched along with Cardiomyopathies in 29 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of nifedipine on the survival rate and the cardiovascular calcinosis were investigated in dietary magnesium (Mg)-deficient mice." | 7.68 | Beneficial effects of a calcium antagonist, nifedipine, on death and cardiovascular calcinosis induced by dietary magnesium deficiency in adult mice. ( Ishiguro, S; Nishio, A; Sakaguchi, H; Sakaguchi, R, 1992) |
| " The study was designed as a side arm of INSIGHT (International Nifedipine Study: Intervention as Goal for Hypertension Therapy), aimed to show the efficacy of nifedipine once daily versus co-amilozide (hydrochlorothiazide 25 mg, amiloride 2." | 5.09 | Calcium channel blocker nifedipine slows down progression of coronary calcification in hypertensive patients compared with diuretics. ( Motro, M; Shemesh, J, 2001) |
| " Nifedipine and diltiazem are effective in the relief of angina, and verapamil is used in the treatment of supraventricular tachyarrhythmias." | 4.77 | Calcium channel blocking agents: physiologic basis of nursing intervention. ( Touloukian, JE, 1985) |
| "The effects of nifedipine on the survival rate and the cardiovascular calcinosis were investigated in dietary magnesium (Mg)-deficient mice." | 3.68 | Beneficial effects of a calcium antagonist, nifedipine, on death and cardiovascular calcinosis induced by dietary magnesium deficiency in adult mice. ( Ishiguro, S; Nishio, A; Sakaguchi, H; Sakaguchi, R, 1992) |
| " Chronic oral administration of nifedipine in combination with atenolol precipitated LV failure only in those with the lowest EF and highest LVEDP; usually LV failure was present with atenolol alone." | 2.66 | Hemodynamic effects of nifedipine given alone and in combination with atenolol in patients with impaired left ventricular function. ( de Buitleir, M; Krikler, DM; Rowland, E, 1985) |
| "The underlying etiology of twin-twin transfusion syndrome (TTTS) is unknown, but our growing understanding of the cardiovascular features of TTTS suggests this may be a disease that could respond to transplacental medical therapy." | 1.40 | Role of adjunctive medical therapy in the fetoscopic surgical treatment of twin-twin transfusion syndrome. ( Crombleholme, TM; Somme, S; Zaretsky, MV, 2014) |
| "Nifedipine treatment significantly prevented STZ-induced increase in cholesterol and triglyceride levels." | 1.29 | Effects of chronic nifedipine treatment on streptozotocin-induced diabetic rats. ( Bangaru, RA; Gandhi, TP; Goyal, RK; Satia, MC; Shah, TS, 1995) |
| "Nifedipine and digoxin were selected as agents to test this hypothesis." | 1.28 | Sodium pump and calcium channel modulation of Mg-deficiency cardiomyopathy. ( Ahmad, A; Bloom, S, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (68.97) | 18.7374 |
| 1990's | 6 (20.69) | 18.2507 |
| 2000's | 1 (3.45) | 29.6817 |
| 2010's | 2 (6.90) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zaretsky, MV | 1 |
| Somme, S | 1 |
| Crombleholme, TM | 2 |
| Lim, FY | 1 |
| Habli, M | 1 |
| Polzin, W | 1 |
| Jaekle, R | 1 |
| Michelfelder, E | 1 |
| Cnota, J | 1 |
| Liu, C | 1 |
| Kim, MO | 1 |
| Braunwald, E | 1 |
| Maurer, E | 1 |
| Nicoletti, R | 1 |
| Brandt, D | 1 |
| Klein, W | 1 |
| Check, WA | 1 |
| Reifart, N | 1 |
| Kober, G | 1 |
| Schulz, W | 1 |
| Kaltenbach, M | 1 |
| Del Guercio, R | 1 |
| Gentile, S | 1 |
| Klugmann, S | 1 |
| Bartoli Klugmann, F | 1 |
| Decorti, G | 1 |
| Gori, D | 1 |
| Silvestri, F | 1 |
| Camerini, F | 1 |
| Schiavoni, G | 1 |
| Mazzari, M | 1 |
| Scabbia, E | 1 |
| Coppola, E | 1 |
| Domenichelli, B | 1 |
| Manzoli, U | 1 |
| Shah, TS | 1 |
| Satia, MC | 1 |
| Gandhi, TP | 1 |
| Bangaru, RA | 1 |
| Goyal, RK | 1 |
| Sato, A | 1 |
| Hattori, Y | 1 |
| Fukao, M | 1 |
| Kanno, M | 1 |
| Sakuma, I | 1 |
| Kitabatake, A | 1 |
| Motro, M | 1 |
| Shemesh, J | 1 |
| Polese, A | 1 |
| Fiorentini, C | 1 |
| Olivari, MT | 1 |
| Guazzi, MD | 2 |
| Sayfie, EJ | 1 |
| Lown, B | 1 |
| D'Amore, F | 1 |
| Ferrera, U | 1 |
| Garassini, G | 1 |
| Schena, V | 1 |
| Finkel, MS | 2 |
| Romeo, RC | 1 |
| Oddis, CV | 1 |
| Salama, G | 1 |
| Sakaguchi, H | 1 |
| Sakaguchi, R | 1 |
| Ishiguro, S | 1 |
| Nishio, A | 1 |
| Sen, LY | 1 |
| O'Neill, M | 1 |
| Marsh, JD | 1 |
| Smith, TW | 1 |
| Bobet, J | 1 |
| Howlett, SE | 1 |
| Gordon, T | 1 |
| Marks, ES | 1 |
| Patterson, RE | 1 |
| Speir, EH | 1 |
| Steadman, K | 1 |
| Keiser, HR | 1 |
| Ahmad, A | 1 |
| Bloom, S | 1 |
| Nahas, G | 1 |
| Trouve, R | 1 |
| Maillet, M | 1 |
| Krog, M | 1 |
| Ejerblad, S | 1 |
| Johansson, H | 1 |
| Wilander, E | 1 |
| Kahan, A | 1 |
| Devaux, JY | 1 |
| Amor, B | 1 |
| Menkès, CJ | 1 |
| Weber, S | 1 |
| Nitenberg, A | 1 |
| Venot, A | 1 |
| Guérin, F | 1 |
| Degeorges, M | 1 |
| Roucayrol, JC | 1 |
| Schwartz, JB | 1 |
| Touloukian, JE | 1 |
| De Cesare, N | 1 |
| Galli, C | 1 |
| Salvioni, A | 1 |
| Tamborini, G | 1 |
| Tosi, E | 1 |
| de Buitleir, M | 1 |
| Rowland, E | 1 |
| Krikler, DM | 1 |
3 reviews available for nifedipine and Cardiomyopathies
| Article | Year |
|---|---|
Mechanism of action of calcium-channel-blocking agents.
Topics: Action Potentials; Angina Pectoris; Arrhythmias, Cardiac; Blood Vessels; Calcium; Calcium Channel Bl | 1982 |
Digoxin and nifedipine.
Topics: Absorption; Administration, Oral; Cardiomyopathies; Digoxin; Drug Interactions; Electrophysiology; G | 1985 |
Calcium channel blocking agents: physiologic basis of nursing intervention.
Topics: Angina Pectoris; Angina Pectoris, Variant; Atrioventricular Node; Calcium; Calcium Channel Blockers; | 1985 |
6 trials available for nifedipine and Cardiomyopathies
| Article | Year |
|---|---|
Effect of calcium antagonists on cardiac performance in patients with dilatative cardiomyopathy evaluated by noninvasive methods.
Topics: Adult; Calcium; Calcium Channel Blockers; Cardiomyopathies; Diltiazem; Drug Therapy, Combination; Ec | 1983 |
Calcium antagonists: long-awaited new therapy for heart disease.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Benzazepines; Calcium; Cardiomyopathies; Clinical Trials as T | 1981 |
[Left ventricular contractility, relaxation and regional wall motion following intracoronary injection of nifedipine. Evaluation by m-mode echocardiography].
Topics: Adult; Aortic Valve Insufficiency; Cardiomyopathies; Coronary Disease; Echocardiography; Female; Hea | 1982 |
Calcium channel blocker nifedipine slows down progression of coronary calcification in hypertensive patients compared with diuretics.
Topics: Aged; Amiloride; Calcinosis; Calcium Channel Blockers; Cardiomyopathies; Coronary Artery Disease; Di | 2001 |
[Nifedipine as a vasodilator antihypertensive with a rapid action].
Topics: Adrenal Gland Neoplasms; Antihypertensive Agents; Brain Diseases; Cardiomyopathies; Emergencies; Hem | 1985 |
Hemodynamic effects of nifedipine given alone and in combination with atenolol in patients with impaired left ventricular function.
Topics: Administration, Oral; Adult; Angiography; Atenolol; Blood Pressure; Cardiac Catheterization; Cardiom | 1985 |
20 other studies available for nifedipine and Cardiomyopathies
| Article | Year |
|---|---|
Role of adjunctive medical therapy in the fetoscopic surgical treatment of twin-twin transfusion syndrome.
Topics: Calcium Channel Blockers; Cardiomyopathies; Female; Fetofetal Transfusion; Fetoscopy; Humans; Nifedi | 2014 |
Improved recipient survival with maternal nifedipine in twin-twin transfusion syndrome complicated by TTTS cardiomyopathy undergoing selective fetoscopic laser photocoagulation.
Topics: Cardiomyopathies; Case-Control Studies; Female; Fetofetal Transfusion; Fetoscopy; Humans; Laser Coag | 2010 |
[Electrocardiographic changes in myocardial damage; effect of treatment with nifedipine].
Topics: Cardiomyopathies; Coronary Disease; Electrocardiography; Female; Humans; Male; Middle Aged; Nifedipi | 1981 |
Adriamycin experimental cardiomyopathy in Swiss mice. Different effects of two calcium antagonistic drugs on ADM - induced cardiomyopathy.
Topics: Animals; Body Weight; Calcium Channel Blockers; Cardiomyopathies; Doxorubicin; Drug Interactions; Mi | 1981 |
[The hemodynamic effects of nifedipine in congestive cardiomyopathy (author's transl)].
Topics: Adolescent; Adult; Cardiomyopathies; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; | 1980 |
Effects of chronic nifedipine treatment on streptozotocin-induced diabetic rats.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Bradycardia; | 1995 |
A role of myofilament Ca2+ sensitivity in enhanced vascular reactivity in cardiomyopathic hamsters.
Topics: Actin Cytoskeleton; Angiotensin II; Animals; Aorta; Calcium; Calcium Channel Blockers; Cardiomyopath | 1998 |
Clinical use of a calcium antagonistic agent (nifedipine) in acute pulmonary edema.
Topics: Adult; Aged; Blood Pressure; Calcium; Cardiomyopathies; Female; Humans; Hypertension; Male; Middle A | 1979 |
Symposium on nifedipine and calcium flux inhibition in the treatment of coronary arterial spasm and myocardial ischemia.
Topics: Calcium; Cardiomyopathies; Coronary Disease; Humans; Nifedipine; Pyridines | 1979 |
Symposium on nifedipine and calcium flux inhibition in the treatment of coronary arterial spasm and myocardial ischemia. Introduction.
Topics: Adult; Angina Pectoris; Calcium; Cardiomyopathies; Coronary Disease; Electrocardiography; Humans; Ma | 1979 |
[Clinical observations on patients with myocardial and coronary sclerosis, myocardial ischemia with anginal attacks and myocardial infarct treated with nifedipine].
Topics: Adult; Aged; Angina Pectoris; Cardiomyopathies; Coronary Disease; Humans; Middle Aged; Myocardial In | 1978 |
Inotropic effects of calcium antagonists in the cardiomyopathic Syrian hamster.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1992 |
Beneficial effects of a calcium antagonist, nifedipine, on death and cardiovascular calcinosis induced by dietary magnesium deficiency in adult mice.
Topics: Animals; Aortic Diseases; Calcinosis; Calcium; Cardiomyopathies; Diet; Magnesium; Magnesium Deficien | 1992 |
Inotropic and calcium kinetic effects of calcium channel agonist and antagonist in isolated cardiac myocytes from cardiomyopathic hamsters.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
Possible mechanisms underlying differences in force production between normal and cardiomyopathic hamster atria.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1991 |
Increased cardiac calcium channels in hamster cardiomyopathy.
Topics: Animals; Calcium; Calcium Channels; Cardiomyopathies; Cricetinae; Ion Channels; Kinetics; Mesocricet | 1986 |
Sodium pump and calcium channel modulation of Mg-deficiency cardiomyopathy.
Topics: Animals; Calcium; Calcium Channels; Cardiomyopathies; Cricetinae; Digoxin; Dose-Response Relationshi | 1989 |
[Prevention of the cardiotoxicity of cocaine using a calcium blocker].
Topics: Animals; Cardiomyopathies; Cocaine; Nifedipine; Nitrendipine; Rats; Rats, Inbred Strains | 1985 |
Tissue calcification and alkaline phosphatase activity in uraemic rats.
Topics: Alkaline Phosphatase; Animals; Aortic Diseases; Calcinosis; Calcitriol; Cardiomyopathies; Creatinine | 1988 |
Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis.
Topics: Adult; Aged; Cardiac Catheterization; Cardiomyopathies; Coronary Circulation; Female; Humans; Male; | 1986 |